跳至主要内容
临床试验/NL-OMON51997
NL-OMON51997已完成不适用

A randomized prospective clinical trial comparing OsteoActivator-P coated membranes vs Collagen Membrane-P uncoated for accelerated localized alveolar ridge preservation. - OsteoActivator-P for accelerated localized alveolar ridge preservation.

Osteo-Pharma.B.V.0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16

研究概览

简要总结

Trial ended prematurely

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Males and females, aged >=18 years.
  • Patient has signed informed consent.
  • Patients with a ruinous dentition (including the canines) in the lower jaw in
  • need of extractions of all teeth of the mandible.
  • Patients in need of a total dental prosthesis in the lower jaw.
  • Patients that want an implant-based denture in the lower jaw.
  • Bone width of at least 7mm
  • Bone height beneath the root-point of the canines at least 10mm

排除标准

  • Absence of the lower canines
  • Concomitant Medication: prescription or nonprescription drugs affecting
  • bone-metabolism, including corticosteroids, gonadotropins, sex steroids (not:
  • contraceptive medication), bisphosphonates, denosumab, parathyroid hormone and
  • calcitonin.
  • History of radiotherapy in the head/neck region
  • Poor oral hygiene
  • Women who are pregnant or breastfeeding
  • Compromised immune system (e.g. uncontrolled diabetis) or unstable bleeding
  • Patients with ASA classification of III or worse
  • Local infection at the site of implantation
  • History of previous ridge augmentation/preservation at the site of interest
  • History of oral cancer or radiation of the oral cavity.
  • Current malignancy
  • Unresolved oral pathologies
  • Patient does not give permission for implantation of porcine membrane.
  • Highly atrophic mandible (Cawood classification V or higher)
  • Known allergy to collagen.
  • Heavy smoking (> 20 cigarettes/day).

研究者

发起方
Osteo-Pharma.B.V.

相似试验